These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12760377)

  • 21. Luteinizing hormone promotes gonadal tumorigenesis in inhibin-deficient mice.
    Nagaraja AK; Agno JE; Kumar TR; Matzuk MM
    Mol Cell Endocrinol; 2008 Nov; 294(1-2):19-28. PubMed ID: 18657590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High levels of luteinizing hormone analog stimulate gonadal and adrenal tumorigenesis in mice transgenic for the mouse inhibin-alpha-subunit promoter/Simian virus 40 T-antigen fusion gene.
    Mikola M; Kero J; Nilson JH; Keri RA; Poutanen M; Huhtaniemi I
    Oncogene; 2003 May; 22(21):3269-78. PubMed ID: 12761497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of Sertoli cell tumour development during the first wave of spermatogenesis in inhibin α-deficient mice.
    Haverfield JT; Stanton PG; Loveland KL; Zahid H; Nicholls PK; Olcorn JS; Makanji Y; Itman CM; Simpson ER; Meachem SJ
    Reprod Fertil Dev; 2017 Mar; 29(3):609-620. PubMed ID: 26488911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic effects of inhibins and müllerian-inhibiting substance on testicular tumorigenesis.
    Matzuk MM; Finegold MJ; Mishina Y; Bradley A; Behringer RR
    Mol Endocrinol; 1995 Oct; 9(10):1337-45. PubMed ID: 8544842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development.
    Matzuk MM; Kumar TR; Shou W; Coerver KA; Lau AL; Behringer RR; Finegold MJ
    Recent Prog Horm Res; 1996; 51():123-54; discussion 155-7. PubMed ID: 8701077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic evidence that SMAD2 is not required for gonadal tumor development in inhibin-deficient mice.
    Rajanahally S; Agno JE; Nalam RL; Weinstein MB; Loveland KL; Matzuk MM; Li Q
    Reprod Biol Endocrinol; 2010 Jun; 8():69. PubMed ID: 20565978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibin gene expression in a large cell calcifying Sertoli cell tumour and serum inhibin and activin levels.
    Toppari J; Kaipia A; Kaleva M; Laato M; de Kretser DM; Krummen LA; Mather JP; Salmi TT
    APMIS; 1998 Jan; 106(1):101-12; discussion 112-3. PubMed ID: 9524568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activin induces x-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin-deficient mice.
    Beuschlein F; Looyenga BD; Bleasdale SE; Mutch C; Bavers DL; Parlow AF; Nilson JH; Hammer GD
    Mol Cell Biol; 2003 Jun; 23(11):3951-64. PubMed ID: 12748296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of mutations affecting gonadotropin production or responsiveness on expression of inhibin subunit mRNA and protein in the mouse ovary.
    Hirst RC; Abel MH; Wilkins V; Simpson C; Knight PG; Zhang FP; Huhtaniemi I; Kumar TR; Charlton HM
    Reproduction; 2004 Jul; 128(1):43-52. PubMed ID: 15232063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibin, activin, follistatin and FSH serum levels and testicular production are highly modulated during the first spermatogenic wave in mice.
    Barakat B; O'Connor AE; Gold E; de Kretser DM; Loveland KL
    Reproduction; 2008 Sep; 136(3):345-59. PubMed ID: 18515316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An activated human follicle-stimulating hormone (FSH) receptor stimulates FSH-like activity in gonadotropin-deficient transgenic mice.
    Haywood M; Tymchenko N; Spaliviero J; Koch A; Jimenez M; Gromoll J; Simoni M; Nordhoff V; Handelsman DJ; Allan CM
    Mol Endocrinol; 2002 Nov; 16(11):2582-91. PubMed ID: 12403847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids.
    Alexander JM; Swearingen B; Tindall GT; Klibanski A
    J Clin Endocrinol Metab; 1995 Jan; 80(1):147-52. PubMed ID: 7829603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activin-β(c) reduces reproductive tumour progression and abolishes cancer-associated cachexia in inhibin-deficient mice.
    Gold E; Marino FE; Harrison C; Makanji Y; Risbridger G
    J Pathol; 2013 Mar; 229(4):599-607. PubMed ID: 23180294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of dimeric inhibins and effects of active immunization against inhibin alpha-subunit on plasma hormones and testis morphology in the developing cockerel.
    Lovell TM; Knight PG; Groome NP; Gladwell RT
    Biol Reprod; 2000 Jul; 63(1):213-21. PubMed ID: 10859262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ageing, testicular tumours and the pituitary-testis axis in dogs.
    Peters MA; de Jong FH; Teerds KJ; de Rooij DG; Dieleman SJ; van Sluijs FJ
    J Endocrinol; 2000 Jul; 166(1):153-61. PubMed ID: 10856894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Male reproductive phenotypes in double mutant mice lacking both FSHbeta and activin receptor IIA.
    Kumar TR; Varani S; Wreford NG; Telfer NM; de Kretser DM; Matzuk MM
    Endocrinology; 2001 Aug; 142(8):3512-8. PubMed ID: 11459797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the testicular phenotype of the follicle-stimulating hormone beta-subunit knockout and the activin type II receptor knockout mice by stereological analysis.
    Wreford NG; Rajendra Kumar T; Matzuk MM; de Kretser DM
    Endocrinology; 2001 Jul; 142(7):2916-20. PubMed ID: 11416011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transgenic mutant D567G but not wild-type human FSH receptor overexpression provides FSH-independent and promiscuous glycoprotein hormone Sertoli cell signaling.
    Allan CM; Lim P; Robson M; Spaliviero J; Handelsman DJ
    Am J Physiol Endocrinol Metab; 2009 May; 296(5):E1022-8. PubMed ID: 19293333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The inhibin/activin signalling pathway in human gonadal and adrenal cancers.
    Marino FE; Risbridger G; Gold E
    Mol Hum Reprod; 2014 Dec; 20(12):1223-37. PubMed ID: 25180271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of ovarian gene expression in follicle-stimulating hormone beta knockout mice.
    Burns KH; Yan C; Kumar TR; Matzuk MM
    Endocrinology; 2001 Jul; 142(7):2742-51. PubMed ID: 11415992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.